Atlas Trials

A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)

Clinical trial NCT05903430 · RECRUITING

Trial details

NCT number
NCT05903430
Sponsor
The Christie NHS Foundation Trust
Status
RECRUITING
Study type
OBSERVATIONAL
Abdominal CancerLung Cancer
Start date
2025-08-29
Primary completion
2027-01-29
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.